Skip to main navigation Skip to search Skip to main content

The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: A call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, st jude global, UICC and WHPCA

  • Kathy Pritchard-Jones*
  • , Simone C. V. de Abib
  • , Natia Esiashvili
  • , Gertjan J. L. Kaspers
  • , Jon Rosser
  • , John A. van Doorninck
  • , João M. L. Braganca
  • , Ruth I. Hoffman
  • , Carlos Rodriguez-Galindo
  • , Cary Adams
  • , Stephen R. Connor
  • , Abdelhafeez H. Abdelhafeez
  • , Eric Bouffet
  • , Scott C. Howard
  • , Julia M. Challinor
  • , Laila Hessissen
  • , Rashmi B. Dalvi
  • , Pamela Kearns
  • , Guillermo L. Chantada
  • , Lindsay A. Frazier
  • Michael J. Sullivan, Fiona S. M. Schulte, Lisa K. Morrissey, Olga Kozhaeva, Sandra Luna-Fineman, Muhammad S. Khan
*Corresponding author for this work
  • University College London
  • International Society of Paediatric Oncology (SIOP)
  • Universidade Federal de São Paulo
  • International Society of Paediatric Surgical Oncology (IPSO), Tienrayseweg 10, 5961NL Horst, The Netherlands
  • Emory University
  • Paediatric Radiation Oncology Society (PROS)
  • Princess Máxima Center for Pediatric Oncology
  • Vrije Universiteit Amsterdam
  • World Child Cancer (WCC),, P.O. Box 113, 3720 AC Bilthoven, The Netherlands
  • World Child Cancer (WCC) UK, 9 Maltings Place, London SE1 3JB, UK
  • University of Colorado Anschutz Medical Campus
  • World Child Cancer (WCC) USA, 1301 Arapahoe St Suite 105, Golden, CO 80401, USA
  • Childhood Cancer International (CCI), Kraijenhoffstraat 137A, 1018RG Amsterdam, The Netherlands
  • St. Jude Children Research Hospital
  • Union for International Cancer Control (UICC), 31-33 Avenue Giuseppe Motta, 1202 Geneva, Switzerland
  • Worldwide Hospice Palliative Care Alliance
  • University of Toronto
  • University of Tennessee Health Science Center
  • University of California at San Francisco
  • Mohammed V University in Rabat
  • Bombay Hospital and Medical Research Centre
  • University of Birmingham
  • European Society for Paediatric Oncology (SIOP Europe), Clos Chapelle-aux-Champs 30, 1200 Brussels, Belgium
  • Otolaryngology-Head and Neck Surgery, Hospital Pereira Rossell, Montevideo, Uruguay
  • Dana-Farber Cancer Institute
  • University of Melbourne
  • University of Calgary
  • Children's Hospital Boston
  • Children's Hospital Colorado Anschutz Medical Campus Aurora, Aurora, CO, USA
  • Tawam Hospital
  • International Society of Paediatric Surgical Oncology (IPSO)
  • World Child Cancer (WCC)
  • World Child Cancer (WCC) UK
  • World Child Cancer (WCC) USA
  • CHILDHOOD CANCER INTERNATIONAL
  • Union for International Cancer Control
  • Hospital for Sick Children University of Toronto
  • European Society for Paediatric Oncology (SIOPE)
  • Hospital Pereira Rossell
  • Harvard University
  • The Children's Hospital, Aurora

Research output: Contribution to journalArticleAcademicpeer-review

10 Downloads (Pure)

Abstract

The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer. The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030. The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live. As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO's call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.
Original languageEnglish
Article number1187
JournalEcancermedicalscience
Volume15
DOIs
Publication statusPublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: A call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, st jude global, UICC and WHPCA'. Together they form a unique fingerprint.

Cite this